About Publisher

Bayrakol Medical Publishing, the official publisher of Eurasian Clinical and Analytical Medicine (ECAM), was founded in 2009 in Turkey with full legal registration. From the beginning, Bayrakol has upheld principles of transparency, legal compliance, and academic integrity.

The publisher's income is derived from book sales, editing and translation services, advertising, and sponsorships. These funding sources are disclosed transparently on the website. Bayrakol communicates regularly with over 20,000 readers and contributors via subscription networks and email bulletins, ensuring wide dissemination of reliable scientific content.

Bayrakol's mission is to deliver accessible, accurate, and globally impactful scientific knowledge. Its vision is to become an internationally recognized academic publisher through rigorous ethical commitment and quality standards.

Bayrakol maintains editorial independence, ensuring no external party influences content decisions. Financial transparency is prioritized, and ethical policies are guided by COPE, ICMJE, and WAME standards. Plagiarism screening tools such as Turnitin and DupliChecker are utilized for all submissions.

A double-blind peer review system is in place. Reviewers are selected for subject-matter expertise, and all identities remain confidential. Ethical breaches are addressed with formal investigation and corrective actions where necessary.

Editorial processes are managed independently by experienced scholars selected for their expertise. Editors receive regular updates and training to stay aligned with evolving ethical norms. All parties are required to disclose potential conflicts of interest.

In the event of misconduct—such as data fabrication or undeclared conflicts—editorial actions include retractions, corrections, or formal statements, in alignment with international best practices.

Bayrakol's digital submission and publication system supports open-access distribution and transparent peer review. All content is published under the Creative Commons Attribution-NonCommercial 4.0 International License. Articles are assigned DOIs to ensure persistent access and citation.

Bayrakol integrates modern tools such as AI-assisted language editing and layout optimization. By publishing in English and engaging with international academic networks, Bayrakol expands its global visibility and scientific reach.

The publisher collaborates with universities and conferences to promote interdisciplinary research, encouraging submission from diverse medical specialties worldwide.

Bayrakol Medical Publishing places strong emphasis on transparent communication with authors, readers, and reviewers. Contact information is clearly provided on all platforms, and inquiries are addressed promptly through appropriate editorial channels.

The publisher issues announcements and calls for papers regularly and provides timely updates regarding publication status, peer review, and index applications. Editorial workflows and decisions are communicated with clarity to ensure accountability.

ECAM maintains an open complaints policy. Complaints regarding editorial decisions, review timelines, or content integrity can be submitted to info@eurasianmed.com. Appeals to editorial decisions are welcomed and assessed independently to ensure fairness. If unresolved, cases may be referred to COPE.

Bayrakol Medical Publishing adheres to global privacy standards, including the General Data Protection Regulation (GDPR). Readers and contributors can manage their data preferences through opt-out features and direct contact with the editorial office.

No data is shared with third parties without user consent. Privacy policies are clearly stated and enforced throughout all publishing processes.

Bayrakol complies with national publishing laws in Turkey as well as international ethical standards. The company maintains transparency with regulatory authorities and indexing databases, preserving long-term trust and legal accountability.